These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study.
    Author: Smits RC, Emmen HH, Bertelsmann FW, Kulig BM, van Loenen AC, Polman CH.
    Journal: Neurology; 1994 Sep; 44(9):1701-5. PubMed ID: 7936300.
    Abstract:
    4-Aminopyridine (4-AP) has a favorable effect on the disability of certain patients with MS. We investigated the effect of 4-AP on neuropsychological performance in 20 MS patients using a randomized, double-blind, placebo-controlled, crossover design. Although there was a trend for improved performance with 4-AP for two of the tests, we could not demonstrate significant effects of 4-AP on cognitive function.
    [Abstract] [Full Text] [Related] [New Search]